AN2 Therapeutics (ANTX)
(Delayed Data from NSDQ)
$2.09 USD
+0.03 (1.46%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $2.09 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.63 | 0.00% |
Earnings Summary
For their last quarter, AN2 Therapeutics (ANTX) reported earnings of -$0.56 per share, beating the Zacks Consensus Estimate of $-0.61 per share. This reflects a positive earnings surprise of 8.20%. Look out for ANTX's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.63 per share, reflecting a year-over-year increase of 22.22%.
Earnings History
Price & Consensus
Zacks News for ANTX
Recent Price Trend in AN2 Therapeutics, Inc. (ANTX) is Your Friend, Here's Why
ANTX: What are Zacks experts saying now?
Zacks Private Portfolio Services